Does TOPOTECAN Cause Pulmonary hypertension? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Pulmonary hypertension have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.5% of all adverse event reports for TOPOTECAN.
16
Reports of Pulmonary hypertension with TOPOTECAN
0.5%
of all TOPOTECAN reports
7
Deaths
16
Hospitalizations
How Dangerous Is Pulmonary hypertension From TOPOTECAN?
Of the 16 reports, 7 (43.8%) resulted in death, 16 (100.0%) required hospitalization, and 5 (31.3%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
AMBRISENTAN (1,504)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
Which TOPOTECAN Alternatives Have Lower Pulmonary hypertension Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE